Literature DB >> 11122904

New insights on the neuroanatomy of schizophrenia.

G D Pearlson1.   

Abstract

Recent ideas and research evidence about the neuroanatomy of schizophrenia come to us from diverse sources. These include 1) conventional (magnetic resonance imaging morphometry); 2) novel (diffusion tensor imaging) structural anatomic techniques; 3) information on patterns of anatomic changes from longitudinal anatomic studies; 4) illumination of functional connectivity and pathway anomalies associated with the disorder; 5) family studies on the distribution of anatomic abnormalities within affected and unaffected family members; and 6) anatomic distributions of neurotransmitters and their receptors, as well as their response to drugs used to treat the disorder. Taken together, these new data provide an exciting look at the direction in which the field is headed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11122904     DOI: 10.1007/s11920-999-0009-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  25 in total

1.  Pathophysiology of 'positive' thought disorder in schizophrenia.

Authors:  P K McGuire; D J Quested; S A Spence; R M Murray; C D Frith; P F Liddle
Journal:  Br J Psychiatry       Date:  1998-09       Impact factor: 9.319

2.  Does dysplasia cause anatomical dysconnectivity in schizophrenia?

Authors:  E T Bullmore; P W Woodruff; I C Wright; S Rabe-Hesketh; R J Howard; N Shuriquie; R M Murray
Journal:  Schizophr Res       Date:  1998-03-10       Impact factor: 4.939

Review 3.  A new framework for investigating antipsychotic action in humans: lessons from PET imaging.

Authors:  S Kapur
Journal:  Mol Psychiatry       Date:  1998-03       Impact factor: 15.992

4.  Implications of normal brain development for the pathogenesis of schizophrenia.

Authors:  D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1987-07

5.  A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures.

Authors:  R E Gur; P Cowell; B I Turetsky; F Gallacher; T Cannon; W Bilker; R C Gur
Journal:  Arch Gen Psychiatry       Date:  1998-02

6.  Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible?

Authors:  M S Keshavan; G L Haas; C E Kahn; E Aguilar; E L Dick; N R Schooler; J A Sweeney; J W Pettegrew
Journal:  J Psychiatr Res       Date:  1998 May-Aug       Impact factor: 4.791

Review 7.  Imaging dopamine transmission in schizophrenia. A review and meta-analysis.

Authors:  M Laruelle
Journal:  Q J Nucl Med       Date:  1998-09

8.  Ventricular enlargement in poor-outcome schizophrenia.

Authors:  K L Davis; M S Buchsbaum; L Shihabuddin; J Spiegel-Cohen; M Metzger; E Frecska; R S Keefe; P Powchik
Journal:  Biol Psychiatry       Date:  1998-06-01       Impact factor: 13.382

9.  Attenuated frontal activation during a verbal fluency task in patients with schizophrenia.

Authors:  V A Curtis; E T Bullmore; M J Brammer; I C Wright; S C Williams; R G Morris; T S Sharma; R M Murray; P K McGuire
Journal:  Am J Psychiatry       Date:  1998-08       Impact factor: 18.112

10.  Brain activations in schizophrenia during a graded memory task studied with functional neuroimaging.

Authors:  P C Fletcher; P J McKenna; C D Frith; P M Grasby; K J Friston; R J Dolan
Journal:  Arch Gen Psychiatry       Date:  1998-11
View more
  1 in total

1.  Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia.

Authors:  Lynne E Rueter; Michael E Ballard; Kelly B Gallagher; Ana Maria Basso; Peter Curzon; Kathy L Kohlhaas
Journal:  Psychopharmacology (Berl)       Date:  2004-06-04       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.